Industry Partnerships
The Crohn’s and Colitis Canada-Vertex Sponsored Research Program is intended to better our understanding of the underlying biology of IBD and to identify potential targets for future IBD medicines.
Researcher Institution
Dr. Dana Philpott University of Toronto
Dr. Maya Saleh McGill University
Dr. Subrata Ghosh University of Calgary
Dr. Scott Gray-Owen
Dr. Brian Coombes
Dr. François Boudreau
University of Toronto
McMaster University
Université Project
The role of isoforms in regulating autophagy
Novel therapeutic targets through genetic and functional analyses of intestinal barrier integrity and cell survival in IBD
Aberrant cell functions driven by IBD associated genetic mutations
Exposing the lifestyle of IBD-related E. coli in the gut
Adherent-invasive E. coli as a polymicrobial colitogenic
Role of HNF4 targets during intestinal de Sherbrooke epithelium regeneration Funding
Year 1 of 2 $ 100,000
Year 1 of 2 $ 100,000
Year 1 of 2 $ 100,000
Year 3 of 3 $ 50,000
Year 3 of 3 $ 75,000
Year 3 of 3 $ 90,580
11 | RESEARCH REPORT 2014
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32